Synlogic, Inc.
(NASDAQ : SYBX)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.05%129.650.0%$2878.82m
BNGOBioNano Genomics, Inc. 21.30%8.430.0%$1523.88m
GILDGilead Sciences, Inc. 1.49%63.331.0%$663.26m
AMGNAmgen, Inc. 1.59%245.491.3%$599.79m
CRSPCRISPR Therapeutics AG -4.84%199.880.6%$544.48m
ALXNAlexion Pharmaceuticals, Inc. 0.03%156.702.0%$501.25m
NVAXNovavax, Inc. -1.96%127.4392.9%$480.66m
REGNRegeneron Pharmaceuticals, Inc. 0.00%517.932.7%$480.32m
ILMNIllumina, Inc. 1.43%376.353.5%$384.71m
BIIBBiogen, Inc. -1.59%275.841.7%$366.50m
VRTXVertex Pharmaceuticals, Inc. -0.25%225.551.9%$350.25m
BNTXBioNTech SE -4.03%101.590.0%$316.33m
SRPTSarepta Therapeutics, Inc. 0.47%90.3213.8%$296.56m
OCGNOcugen, Inc. 1.84%2.220.0%$276.18m
EDITEditas Medicine, Inc. 0.29%76.147.9%$256.07m

Company Profile

Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.